Takeaways
#- The speaker challenges the downgrade and says the group was buying the dip.
- His comments are an opinion at recording time and do not establish the analyst’s motives or misconduct.
The speaker in this Morning Show excerpt disagrees with a Citi sell recommendation on Moderna and describes buying the dip instead. He also points to what he describes as the stock's subsequent Nasdaq-100 inclusion as part of his criticism of the call.
The exchange shows how differently a market participant can respond to an analyst downgrade. The sell rating is treated by the speaker as something to challenge, rather than an instruction to follow.
The clip does not supply a complete valuation case, an entry price or a risk limit for that purchase. It also does not substantiate claims about the analyst's motives. The supported takeaway is the disagreement itself and the speaker's stated response at the time, not a finding of improper conduct or a current recommendation to buy the shares.
Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .